<DOC>
	<DOCNO>NCT00286078</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness implantable device difficult treat migraine . There significant number patient drug refractory migraine alternative therapy need .</brief_summary>
	<brief_title>Treatment Migraines With Implantable Device</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Be diagnose multiple migraine per month moderate severe intensity ; Be refractory medication ; Be appropriate candidate surgical procedure require study ; Be willing able comply study related procedure ; Be capable read understanding patient information material give write informed consent . Exclusion : Have onset migraine age 50 ; Have significant psychiatric disorder ; Have previously treat occipital nerve stimulation ; Have injection botulinum toxin head neck within 6 month prior enrollment ; Have previously undergone destructive ganglionectomy affect C2/C3 occipital and/or trigeminal distribution occipital blockade radio frequency procedure currently effect ; Have condition currently require likely require use MRI diathermy ; Have active implantable device ; Have participate drug device trial last 4 week plan participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Headache</keyword>
	<keyword>Migraine</keyword>
	<keyword>Refractory</keyword>
	<keyword>Chronic</keyword>
	<keyword>Pain</keyword>
</DOC>